These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

474 related articles for article (PubMed ID: 17716297)

  • 21. Molecular mechanisms of leptin and adiponectin in breast cancer.
    Jardé T; Perrier S; Vasson MP; Caldefie-Chézet F
    Eur J Cancer; 2011 Jan; 47(1):33-43. PubMed ID: 20889333
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Obesity, metabolic syndrome and sleep apnoea: all pro-inflammatory states.
    Alam I; Lewis K; Stephens JW; Baxter JN
    Obes Rev; 2007 Mar; 8(2):119-27. PubMed ID: 17300278
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Abdominal adiposity and cardiometabolic risk: do we have all the answers?
    Haffner SM
    Am J Med; 2007 Sep; 120(9 Suppl 1):S10-6; discussion S16-7. PubMed ID: 17720354
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adiponectin: a key adipocytokine in metabolic syndrome.
    Okamoto Y; Kihara S; Funahashi T; Matsuzawa Y; Libby P
    Clin Sci (Lond); 2006 Mar; 110(3):267-78. PubMed ID: 16464169
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Psoriasis independently associated with hyperleptinemia contributing to metabolic syndrome.
    Chen YJ; Wu CY; Shen JL; Chu SY; Chen CK; Chang YT; Chen CM
    Arch Dermatol; 2008 Dec; 144(12):1571-5. PubMed ID: 19075139
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum adiponectin as a useful marker for metabolic syndrome in type 2 diabetic patients.
    Yun JE; Sull JW; Lee HY; Park E; Kim S; Jo J; Lee SJ; Kim SY; Choi YJ; Jee SH; Huh KB
    Diabetes Metab Res Rev; 2009 Mar; 25(3):259-65. PubMed ID: 19214966
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum adiponectin confers little protection against diabetes and hypertension in Turkish men.
    Onat A; Hergenç G; Can G; Küçükdurmaz Z
    Obesity (Silver Spring); 2009 Mar; 17(3):564-70. PubMed ID: 19238142
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Markers of pro-inflammatory and pro-thrombotic state in the diagnosis of metabolic syndrome.
    Odrowaz-Sypniewska G
    Adv Med Sci; 2007; 52():246-50. PubMed ID: 18217426
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The dark side of testosterone deficiency: I. Metabolic syndrome and erectile dysfunction.
    Traish AM; Guay A; Feeley R; Saad F
    J Androl; 2009; 30(1):10-22. PubMed ID: 18641413
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Altered plasma adipokines and markers of oxidative stress suggest increased risk of cardiovascular disease in First Nation youth with obesity or type 2 diabetes mellitus.
    Stringer DM; Sellers EA; Burr LL; Taylor CG
    Pediatr Diabetes; 2009 Jun; 10(4):269-77. PubMed ID: 19175895
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Obesity, type 2 diabetes and risk of digestive cancer.
    Hillon P; Guiu B; Vincent J; Petit JM
    Gastroenterol Clin Biol; 2010 Oct; 34(10):529-33. PubMed ID: 20864282
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adipokines and etiopathology of metabolic disorders.
    Al-Dokhi LM
    Saudi Med J; 2009 Sep; 30(9):1123-32. PubMed ID: 19750255
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Leptin to adiponectin ratio, as an index of insulin resistance and atherosclerosis development].
    Kieć-Klimczak M; Malczewska-Malec M; Huszno B
    Przegl Lek; 2008; 65(12):844-9. PubMed ID: 19441676
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Physical activity is associated with risk factors for chronic disease across adult women's life cycle.
    Woolf K; Reese CE; Mason MP; Beaird LC; Tudor-Locke C; Vaughan LA
    J Am Diet Assoc; 2008 Jun; 108(6):948-59. PubMed ID: 18502225
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adverse effects of obesity on breast cancer prognosis, and the biological actions of leptin (review).
    Rose DP; Gilhooly EM; Nixon DW
    Int J Oncol; 2002 Dec; 21(6):1285-92. PubMed ID: 12429979
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulating adiponectin levels associate with inflammatory markers, insulin resistance and metabolic syndrome independent of obesity.
    Hung J; McQuillan BM; Thompson PL; Beilby JP
    Int J Obes (Lond); 2008 May; 32(5):772-9. PubMed ID: 18253163
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular mechanisms of insulin resistance and associated diseases.
    Mlinar B; Marc J; Janez A; Pfeifer M
    Clin Chim Acta; 2007 Jan; 375(1-2):20-35. PubMed ID: 16956601
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Adiponectin and its role in the pathogenesis of obesity, diabetes mellitus and insulin resistance].
    Owecki M; Sowiński J
    Pol Merkur Lekarski; 2006 Mar; 20(117):355-7. PubMed ID: 16780274
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Correlations of insulin resistance and neoplasms].
    Suba Z; Ujpál M
    Magy Onkol; 2006; 50(2):127-35. PubMed ID: 16888676
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Obesity and prostate cancer: a role for adipokines.
    Mistry T; Digby JE; Desai KM; Randeva HS
    Eur Urol; 2007 Jul; 52(1):46-53. PubMed ID: 17399889
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.